Lanyu Bio completed the D+ round of financing of nearly 100 million yuan

Lanyu Bio is a biological company dedicated to the research and development, production and sales of in vitro diagnostic reagents and instruments. It has established a combination of immunological, molecular, cytology and other methodological platforms based on active microfluidic technology and intelligent instrument platform development. Precision medical system with integrated inspection system. Recently, Lanyu Bio announced the completion of the D+ round of financing of nearly 100 million yuan. This round of financing was led by government funds, and Yikai Capital served as the exclusive financial advisor for this round. Lanyu Biology once again received capital blessing. This round of funds will be mainly used to expand the local and overseas market layout and accelerate the company’s channel network sinking to the terminal.

This article is reproduced from:
This site is for inclusion only, and the copyright belongs to the original author.

Leave a Comment